Phase 1 results disclosed Monday indicate the company’s protein-degrading drug can affect a tough-to-reach target called ...

KEY TAKEAWAYS French drugmaker Sanofi said Monday it has agreed to acquire Blueprint Medicines for up to $9.5 billion, sending shares of the Cambridge, Mass.-based biopharma firm soaring in intraday ...

ONGC, Indigo, Colgate, Oil India, IndusInd Bank, NTPC Green Energy, Power Finance Corporation, and Rail Vikas Nigam among 133 companies to release their earnings report today.

It used to be that Chinese drug development was largely about creating "me too" drugs for the local market. But over the past 10 years, with Beijing focussed on building a native biotech industry, US- ...

(Photo: Getty Images) Generic versions of the popular diabetes drug Empagliflozin have reached the market after Boehringer Ingelheim's patent expired on March 11. The German pharmaceutical company ...

Shares of Mankind Pharma slipped 4 percent to Rs 2,606, snapping its two-day gaining streak on the bourses on January 21 after Macquarie downgraded Mankind Pharma to "Underperform" with a target ...

Mankind Pharma Limited on Thursday announced that it has entered into a partnership with Innovent Biologics to exclusively license and commercialize sintilimab, an advanced PD-1 immunotherapy ...

Mankind Pharma Limited on Wednesday announced that it has completed the transaction to acquire 100% stake in Bharat Serums and Vaccines Limited (BSV), for a purchase consideration of Rs.

The competition commission of India (CCI) has approved the acquisition of Bharat Serums and Vaccines Ltd (BSV) by Mankind Pharma Ltd. The proposed transaction involves the acquisition of 100% ...

Mankind Pharma: The pharmaceutical major plans to raise up to Rs ... and IDBI Trusteeship Services withdrew their petitions challenging the merger of Zee Entertainment and Sony Pictures Networks India ...

Brothers Ramesh (left) and Rajeev Juneja at Mankind Pharma's headquarters in Delhi. Mankind Pharma—owned by Indian billionaire brothers Ramesh and Rajeev Juneja— has agreed to buy Bharat ...

Mankind Pharma Ltd said it had entered into a definitive agreement to acquire a 100% stake in Bharat Serums and Vaccines Ltd (BSV) from private equity firm Advent International for an enterprise ...